Dr. White is Assistant Professor of Pharmacy Practice, University of Connecticut, Storrs. He also Codirector of Arrhythmia Research, Department of Pharmacy Services at Hartford (CT) Hospital.
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Eslicarbazepine acetate (eslicarbazepine, or ESL) is a new antiepileptic agent awaiting FDA approval.
Dronedarone: An antiarrhythmic agent for the management of atrial fibrillation and atrial flutter
Dronedarone, an investigational antiarrhythmic agent being studied for the management of AF and atrial flutter, has a pharmacologic mechanism of action that is similar to that of amiodarone, but dronedarone lacks an iodine moiety, which may result in less thyroid and pulmonary toxicity. Dronedarone is currently pending FDA approval; the agent was granted priority review in August 2008.
2 Clarke Drive Cranbury, NJ 08512